Algert Global LLC bought a new position in shares of UnitedHealth Group Incorporated (NYSE:UNH) during the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor bought 2,564 shares of the healthcare conglomerate’s stock, valued at approximately $1,027,000.
Other hedge funds have also recently bought and sold shares of the company. Jennison Associates LLC boosted its position in shares of UnitedHealth Group by 205.8% in the 2nd quarter. Jennison Associates LLC now owns 1,947,717 shares of the healthcare conglomerate’s stock worth $779,944,000 after purchasing an additional 1,310,783 shares in the last quarter. Capital International Investors boosted its position in shares of UnitedHealth Group by 5.8% in the 1st quarter. Capital International Investors now owns 18,899,258 shares of the healthcare conglomerate’s stock worth $7,032,097,000 after purchasing an additional 1,040,094 shares in the last quarter. Lazard Asset Management LLC boosted its position in shares of UnitedHealth Group by 185.4% in the 1st quarter. Lazard Asset Management LLC now owns 1,178,666 shares of the healthcare conglomerate’s stock worth $438,545,000 after purchasing an additional 765,729 shares in the last quarter. Ontario Teachers Pension Plan Board bought a new stake in shares of UnitedHealth Group in the 1st quarter worth approximately $266,424,000. Finally, Geode Capital Management LLC boosted its position in shares of UnitedHealth Group by 4.7% in the 2nd quarter. Geode Capital Management LLC now owns 15,110,522 shares of the healthcare conglomerate’s stock worth $6,033,290,000 after purchasing an additional 679,484 shares in the last quarter. Hedge funds and other institutional investors own 86.21% of the company’s stock.
UNH has been the topic of several analyst reports. Morgan Stanley lowered their price objective on UnitedHealth Group from $515.00 to $488.00 and set an “overweight” rating on the stock in a research report on Tuesday, August 31st. Cowen initiated coverage on UnitedHealth Group in a research report on Thursday, September 9th. They issued an “outperform” rating and a $478.00 price objective on the stock. Truist Securities upped their price objective on UnitedHealth Group from $480.00 to $500.00 and gave the company a “buy” rating in a research report on Friday, July 16th. SVB Leerink initiated coverage on UnitedHealth Group in a research report on Monday, September 27th. They issued an “outperform” rating and a $480.00 price objective on the stock. Finally, Seaport Res Ptn reissued a “buy” rating on shares of UnitedHealth Group in a report on Friday, July 9th. Three analysts have rated the stock with a hold rating, twenty have given a buy rating and one has given a strong buy rating to the company’s stock. According to MarketBeat.com, the company presently has an average rating of “Buy” and an average target price of $447.79.
Shares of NYSE:UNH traded up $21.47 during midday trading on Thursday, hitting $425.02. The company had a trading volume of 147,787 shares, compared to its average volume of 2,968,564. The company has a debt-to-equity ratio of 0.62, a current ratio of 0.77 and a quick ratio of 0.77. The company has a market cap of $400.76 billion, a price-to-earnings ratio of 26.65, a PEG ratio of 1.62 and a beta of 0.77. UnitedHealth Group Incorporated has a 12-month low of $299.60 and a 12-month high of $431.36. The company has a fifty day moving average of $411.69 and a two-hundred day moving average of $405.33.
UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings results on Thursday, October 14th. The healthcare conglomerate reported $4.52 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $4.41 by $0.11. UnitedHealth Group had a return on equity of 22.15% and a net margin of 5.33%. The business had revenue of $72.34 billion during the quarter, compared to analyst estimates of $71.24 billion. During the same quarter in the prior year, the business posted $3.51 EPS. UnitedHealth Group’s revenue for the quarter was up 11.1% compared to the same quarter last year. Research analysts expect that UnitedHealth Group Incorporated will post 18.74 earnings per share for the current fiscal year.
The business also recently disclosed a quarterly dividend, which was paid on Tuesday, September 21st. Shareholders of record on Monday, September 13th were issued a dividend of $1.45 per share. This represents a $5.80 annualized dividend and a dividend yield of 1.36%. The ex-dividend date of this dividend was Friday, September 10th. UnitedHealth Group’s dividend payout ratio (DPR) is presently 34.36%.
UnitedHealth Group Company Profile
UnitedHealth Group, Inc engages in the provision of health care coverage, software, and data consultancy services. It operates through the following segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment utilizes Optum’s capabilities to help coordinate patient care, improve affordability of medical care, analyze cost trends, manage pharmacy benefits, work with care providers more effectively, and create a simpler consumer experience.
Featured Article: Death Cross
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.